...Brigham and Women's Hospital, pioneering genomic research that identifies BAP1, CDKN2A, and other critical mutations.
...Raphael Bueno, International Mesothelioma Program, mesothelioma genomics, BAP1 mutation, CDKN2A, Brigham and Women's Hospital, personalized medicine
...
24 KB (3,109 words) - 19:06, 20 May 2026
...prognosis covering validated scoring systems (EORTC, CALGB, Brims, PLECH), BAP1 mutations, blood biomarkers, and factors that improve individual outcomes.
...prognosis, prognostic factors mesothelioma, mesothelioma scoring systems, BAP1 mesothelioma, mesothelioma long-term survival, PLECH score, mesothelioma li
...
45 KB (5,643 words) - 23:25, 14 May 2026
|title=Mesothelioma Molecular and Genetic Testing: BAP1, CDKN2A, NGS Panels & Biomarker-Guided Treatment
...ehensive guide to molecular and genetic testing for mesothelioma including BAP1 mutations, CDKN2A FISH, NF2 inactivation, next-generation sequencing panels
...
55 KB (7,216 words) - 23:25, 14 May 2026
...ostic advances 2023-2026: IASLC TNM 9th edition pleural thickness staging, BAP1+MTAP IHC, cfMeDIP-seq liquid biopsy, AI pathology, ASCO 2025.
|keywords=mesothelioma diagnostic technology, TNM 9th edition mesothelioma, BAP1 IHC, MTAP IHC, cfMeDIP-seq, AI pathology mesothelioma, pleural thickness st
...
39 KB (4,780 words) - 23:07, 14 May 2026
...substantially higher proportion than for pleural mesothelioma, reflecting BAP1 germline mutations and secondary exposure as additional causes<ref name="pm
...le patients with secondary (paraoccupational) exposure, a greater role for BAP1 germline mutations, and incomplete occupational histories.
...
32 KB (3,931 words) - 23:26, 14 May 2026
...oma, calretinin, mesothelioma misdiagnosis, PET CT mesothelioma, MESOMARK, BAP1, epithelioid mesothelioma, sarcomatoid mesothelioma, peritoneal cancer inde
...age groupings.<ref name="jtd_staging" /> Emerging molecular testing for '''BAP1''', '''CDKN2A''', and other genetic alterations is increasingly important f
...
58 KB (7,639 words) - 23:25, 14 May 2026
...vs peritoneal differences, biological mechanisms, genetic predisposition (BAP1/RAD51), and courtroom implications for statute of limitations.
...neal mesothelioma latency, mesothelioma in situ, pleural plaques timeline, BAP1 mutation, RAD51 mutation, mesothelioma diagnosis gap
...
53 KB (7,021 words) - 23:25, 14 May 2026
...-meso" /> Current research into CAR-T cell therapy, gene therapy targeting BAP1 mutations, and novel immunotherapy combinations continues to push the bound
...d precision medicine''' — The discovery that 44-60% of mesotheliomas carry BAP1 mutations opened the door to gene therapy and targeted treatment strategies
...
38 KB (4,762 words) - 23:25, 14 May 2026
| '''Interaction with BAP1 and CDKN2A''' || BRCA1-associated protein 1 (BAP1) is somatically inactivated in ~57–60% of MPM and drives polycomb-mediated
...tion awaiting full-text data; the mechanisms are mechanistically adjacent (BAP1 loss drives polycomb-mediated H3K27 histone trimethylation, whereas methyla
...
36 KB (4,576 words) - 21:55, 25 May 2026
* '''BAP1 mutation paradox''' — Patients with this genetic alteration survive 5x long
...ive biomarkers for immunotherapy response. Patients with triple mutations (BAP1/CDKN2A/CDKN2B) plus PD-L1 positivity achieved median survival of 15.8 month
...
37 KB (4,496 words) - 23:26, 14 May 2026
...oracentesis mesothelioma, pleural biopsy accuracy, IHC panel mesothelioma, BAP1 biopsy, CDKN2A FISH biopsy
...ardized marker panels, conducting ancillary molecular testing including '''BAP1 loss''' and '''CDKN2A FISH''', and developing an evidence-based treatment p
...
60 KB (7,904 words) - 23:25, 14 May 2026
...Sterman, mesothelioma clinical trials, tumor suppressor gene replacement, BAP1 mesothelioma, CRISPR mesothelioma
* BAP1 is the most commonly mutated gene in mesothelioma (~60% of cases), and its
...
67 KB (8,772 words) - 23:06, 14 May 2026
...tients — covering diagnostic fluid analysis, cytology sensitivity (45.1%), BAP1/MTAP biomarkers, ultrasound guidance, complications, IPC vs pleurodesis com
...ral effusion drainage, malignant pleural effusion, pleural fluid cytology, BAP1 immunohistochemistry, MTAP mesothelioma, ultrasound guided thoracentesis, i
...
69 KB (8,834 words) - 23:25, 14 May 2026
...non-asbestos causes—including erionite, radiation, genetic predisposition (BAP1 mutations), carbon nanotubes, and spontaneous mesothelial transformation—in
=== BAP1 Tumor Predisposition Syndrome ===
...
42 KB (5,304 words) - 23:25, 14 May 2026
...ivity together with CEA, TTF-1, claudin-4, and BerEP4 negativity — plus '''BAP1''' and '''CDKN2A/MTAP''' loss assessment is the current standard for distin
...5/6 + D2-40 positive with CEA + TTF-1 + claudin-4 + BerEP4 negative, plus BAP1 and CDKN2A/MTAP loss assessment<ref name="mansour_2023" /><ref name="nabesh
...
27 KB (3,510 words) - 03:54, 25 May 2026
...tomy decortication, P/D recurrence pattern, local recurrence mesothelioma, BAP1 mesothelioma prognosis, salvage surgery mesothelioma, IOHC HITHOC mesotheli
| style="padding:10px;" | BAP1 alt 44%; CDKN2A HD ~49–75%; NF2 33%
...
54 KB (6,833 words) - 18:35, 25 May 2026
| style="padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;" | BAP1 Germline Carrier Median OS
Germline mutations in BAP1 (BRCA-Associated Protein 1) are a special case: BAP1 carriers tend to present younger, often with multifocal low-grade tumors, a
...
37 KB (4,776 words) - 01:09, 26 May 2026
== What Role Do BAP1, TMB, and Other Biomarkers Play? ==
=== BAP1 Mutations ===
...
63 KB (8,147 words) - 05:05, 25 May 2026
...0px; border-bottom:1px solid #dee2e6;" | Recurrent inactivation of CDKN2A, BAP1, NF2, and TP53 tumor suppressors, matching pleural mesothelioma patterns (S
...n asbestos-related pleural mesothelioma — including alterations in CDKN2A, BAP1, NF2, and TP53 — are also present in pericardial mesothelioma. This shared
...
55 KB (6,929 words) - 23:25, 14 May 2026
...with the immunohistochemistry panels — calretinin, WT-1, D2-40, claudin-4, BAP1, and MTAP — required to distinguish mesothelioma from its imitators.<ref na
...tivity and 94–100% specificity for carcinoma versus mesothelioma). Loss of BAP1 nuclear staining and MTAP deletion by FISH are additional discriminators fo
...
39 KB (5,219 words) - 23:25, 14 May 2026
